Start up. Grow up. Succeed.

News 2020

Immunic, Inc. Announces Pricing of $15 Million Financing

NEW YORK, April 23, 2020 – Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced that it h...

Neurimmune and Ethris Sign Collaboration Agreement to Rapidly Develop Inhaled mRNA-based Antibody Therapy for the Treatment of Covid-19

-- Companies expect to initiate clinical testing in 2020 -- Zurich, Switzerland and Munich, Germany, April 1, 2020 – Neurimmune AG and Ethris GmbH announced today an exclusive partnership to develop mRNA-encoded, neutralizing anti-SARS-CoV-2 antibodies ...

SimScale Closes €27 Million in Series C Financing Led by Insight Partners

Investment to help accelerate the expansion of SimScale’s cloud-based engineering simulation platform for customers Munich, Germany – January 30, 2020 –  SimScale, the provider of the world’s first production-ready SaaS applicatio...

Enscape receives Strategic Investment by Private Equity Firm, LEA Partners

New stake to accelerate innovation and international expansion at one of the AEC’s fastest-growing real-time rendering SaaS companies Karlsruhe, Germany (February 4th, 2020) — Enscape GmbH, a leading provider of real-time 3D rendering and visualiz...